What is the cost of Yescarta?

The cost of Yescarta, as reported by the manufacturer, is $373,000 per treatment regimen.A personalized and complicated engineering process such as CAR T cell development is expected to be costly.

Factors that contribute to the cost of CAR-T cell therapy include:

• Specialized facilities and health care providers
• Individualized manufacturing costs for personalized therapy
• Possible need for intensive care post-infusion due to serious adverse events
• Prolonged hospitalization

Yescarta (axicabtagene ciloleucel), from Kite Pharma/Gilead is a chimeric antigen receptor T cell (CAR T) therapy used for adults with large B-cell lymphoma after failing at least two other treatments.